Find out more about how The Lecture List works.
Coronavirus situation updateOur lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE. |
Find out what you can do to keep The Lecture List online
|
THIS EVENT HAS BEEN CANCELLED
Beyond the Genome: the challenge of synthetic biology
The 1970s introduced genetic modification, the 1990s cloning and GM food, and the human genome was sequenced in 2000. Synthetic biology is heralded as the next frontier. But what is synthetic biology and how do we imagine its future directions? What are the implications of this new field for scientists, lawyers, regulators and ethicists? What social and political challenges does it pose and what role will the social sciences, the humanities and the public play in shaping the direction of this new field? The expert panel will debate these issues with the audience.
Professor Sarah Franklin is Associate Director of BIOS, Professor in Sociology and Convenor for the MSc in Biomedicine, Bioscience and Society at LSE. Peter Lipton is head of the Department of History and Philosophy of Science, Cambridge University. Chris Mason is head of the Stem Cell and Regenerative Medicine Bioprocessing Unit at UCL. J Craig Venter is founder, chairman and president of the J Craig Venter Institute.
This event has been organised in conjunction with the Royal Society of Arts and Penguin Books, publishers of Craig Venter's autobiography A Life Decoded.
Speaker(s): |
Professor Sarah Franklin | talks |
|
|
Date and Time: |
24 October 2007 at 7:00 pm |
Duration: | 1 hour 30 minutes |
|
|
Venue: |
Old Theatre |
Organised by: |
London School of Economics & Political Science |
|
|
Tickets: |
Free |
Available from: |
|
Additional Information: |
For more information email events@lse.ac.uk or call 020 7955 6043 |
Register to tell a friend about this lecture.
If you would like to comment about this lecture, please register here.
Any ad revenue is entirely reinvested into the Lecture List's operating fund